2 results
Approved WMORecruiting
The anti-TIM-3 monoclonal antibody MBG453 is a novel immunotherapeutic agent with promising activity seen in AML and MDS. The purpose of the current study is to assess clinical effects of MBG453 in combination with azacitidine in adult subjects with…
Approved WMORecruiting
The objective of the proposed study is to assess the effectiveness and cost-effectiveness of the use of oil versus water-based contrast medium in terms of live birth in women undergoing HSG, who:1: have ovulation disorders or;2: are at high risk for…